SUMMARY
INTRODUCTION
Gestational trophoblastic diseases belong to a group of diseases that occur because of the abnormal proliferation of trophoblasts which are present in placenta. They are histologically classified as complete and partial hydatidiform mole, invasive mole, choriocarcinoma and placental site trophoblastic tumour (1) 
Incidence of the disease which is the only gynecologic malignancy with androgenic origin varies according to the geographical regions (2) . While it is rarer in North American and European countries, its incidence has been determined as 0.3-16.0/1000 pregnancies and 1.0-24.5/1000 births in Turkey (3) . Socio-economical status, blood group, menarche age, maternal age, parity, previous molar pregnancy history, genetic factors, malnutrition, parasites and infections are among the risk factors (4) .
In this study, it was aimed to evaluate the patients followed and treated between the dates of 1. First of all, pelvic and physical examination, serum β- For the purpose of final diagnosis and treatment, initially vacuum curettage was performed on patients under the operating room conditions. Hysterectomy was conducted on the suitable patients by taking the patient's age and parity into consideration. Patients were monitored for serum β-hCG after vacuum curettage.
MATERIAL AND METHODS

Of
They were followed weekly until their serum β-hCG values were under 5mIU/ml for 3 times consecutively and then they were followed monthly for 1 year. During push. Weekly β-hCG follow-ups were continued after the chemotherapy. Chemotherapy was carried on until β-hCG level was normal for 3 times consecutively.
Oral contraceptive was recommended as the contraceptive method for all the patients followed. (Table I) . Menarche ages were varying between 11 and 15, and were calculated as a mean of 12.68 ± 0.83. Seventy one percent of the patients were housewives, 77.6 % were illiterate and income of 66 % was low. While 22 cases (15%) were primigravid, gravidity number of 40 cases (27.2%) changed between 5 and 9, and gravidity of 9 cases (6.1%) was more than 15 (Table II) . It was determined that 27 of the patients were nulliparous (18.4%) and parity of 3 patients (2.1%) was determined as more than 15 (Table III) . When blood groups were examined; it was monitored that 69 patients (46.9%) were A, 25 (17%) were B, 17 (11.6%) were AB and 36 (24.5%) were 0 type. When contraceptive methods were examined; it was monitored that 3 patients (2%) used IUD (intra uterine device), 1 (0.7%) used oral contraceptive, 7 (4.8%) used coitus interruptus method, 1 (0.7%) used condoms whereas 113 patients (76.9%) didn't use any contraceptive methods. Contraception information of 22 patients (15%) couldn't be collected.
RESULTS
Between the dates
In 47 of the patients (32%) history of spontaneous abortion; in 6 (4.1%) molar pregnancy; in 94 (63.9%) term birth history in the previous pregnancy; in 76 (51.7%) hyperthyroidism; in 22 (15%) hyperemesis; in 5 (3.4%) preeclampsia and in 2 (1.4%) eclampsia was determined (Table IV) . 
DISCUSSION
Gestational trophoblastic diseases contain a group of benign and malign diseases pathogenesis of which isn't clarified exactly (5) . Different incidences have been reported as a result of epidemiological studies all around the world. It has been shown in the society based studies that molar pregnancy incidence in South
East Asian countries are 2-3 times more than that of the European countries (6) . While hydatidiform mole incidence is 11.5/1000 births in Indonesia, it is less than 1/1000 in America (4) . Mole pregnancy incidence in Japan was determined as 2.5/1000 live births in 1974 and started to decrease dating from 1991, and determined as 1.65/1000 live births in 2000 (7) . In been stated that frequency risk of the disease under the age of 20 increases 1.5 times and 5.2 times above the age of 40 (11) .
While most frequent admission complaint is vaginal bleeding, symptoms of passage of vesicles, hyperemesis, hyperthyroidism and preeclampsia may accompany. Apart from these, abnormal findings such as trophoblastic embolism, adult respiratory distress syndrome (ARDS), hypovolemic shock, anemia, heart failure may appear (12) . In our study, it was monitored that patients attended most frequently with the complaint of vaginal bleeding (77.6%) followed by menstrual delay (10.2%), pain (9.5%), nausea and pregnancies (13) . In this research it was also monitored that most of the patients (46.9%) have the blood group A.
When gravidities of the patients were compared; gestational trophoblastic disease frequency in the women with the gravidity number 5 and above was determined as statistically significantly higher than the primigravids (p=0.001). Similarly, more gestational trophoblastic diseases were determined in grand multipars with the parity of 5 and over compared to nullipars (p=0.001).
First option in the diagnosis and treatment of molar pregnancy is vacuum curettage. Hysterectomy may also be considered as one of the treatment methods for the patients who completed fertility. All the patients should be followed with serial hCG measurements after the vacuum curettage (1, 12, 14) . Vacuum curettage with oxytocin infusion was performed under general anesthesia on 140 patients in the study. Perforation developed in one of them during the curettage procedure. They were followed weekly until negative serum β-hCG values were obtained for 3 times consecutively and then their hCG values were followed monthly for 1 year. Oral contraceptives were recommended to the patients for 12 months as stated in the literature after their serum β-hCG values were negative. By this way, both contraception and repression of LH that can cross react with and hCG was provided (15) .
Main treatment method for gestational trophoblastic neoplasias is chemotherapy and some protocols with single and multi agents were determined. Chemotherapy wasn't performed on 115 patients whereas single agent chemotherapy was performed on 26 patients and multi agent EMA-CO and EP/EMA combined chemotherapy were performed on 6 patients.
In conclusion, majority of our patients have a low socio-economical status and education. Incidence in our clinic is higher than the incidences determined in some studies in the literature. Decreasing of the high gravidity and parity ratios in our region may contribute to the decrease in the incidence of this disease.
KAYNAKLAR
